Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2013, Article ID 546578, 3 pages
http://dx.doi.org/10.1155/2013/546578
Case Report

Fatal Disseminated Kaposi's Sarcoma due to Immune Reconstitution Inflammatory Syndrome following HAART Initiation

Division of Infectious Disease, University of São Paulo, Avenida Dr. Enéas de Carvalho Aguiar, 255, 4°Andar, 05403-900 São Paulo, SP, Brazil

Received 21 April 2013; Accepted 18 June 2013

Academic Editors: W. I. van der Meijden and K. Yeboah-Antwi

Copyright © 2013 Fatuma Catherine Atieno Odongo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Lu, S. Y. Chang, Y. T. Tseng et al., “Immune reconstitution inflammatory syndrome of Kaposi's sarcoma in an HIV-infected patient,” Journal of Microbiology, Immunology and Infection, 2012. View at Publisher · View at Google Scholar
  2. K. R. Stover, S. Molitorisz, E. Swiatlo, and C. A. Muzny, “A fatal case of kaposi sarcoma due to immune reconstitution inflammatory syndrome,” The American Journal of the Medical Sciences, vol. 343, no. 5, pp. 421–425, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Letang, J. M. Almeida, J. M. Miró et al., “Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 5, pp. 589–597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. W. X. Guo, T. Antakly, M. Cadotte et al., “Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma,” The American Journal of Pathology, vol. 148, no. 6, pp. 1999–2008, 1996. View at Google Scholar · View at Scopus
  5. E. Connick, M. A. Kane, I. E. White, J. Ryder, and T. B. Campbell, “Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy,” Clinical Infectious Diseases, vol. 39, no. 12, pp. 1852–1855, 2004. View at Publisher · View at Google Scholar · View at Scopus